Download PDF
CC BY 4.0 · Brazilian Journal of Oncology 2020; 16: e-20200008
DOI: 10.5935/2526-8732.20200008
Original Article
Oncological Surgery

Brazilian Society of Surgical Oncology (BSSO) considerations on peritoneal surface malignancies management during COVID-19 pandemic

Considerações da Sociedade Brasileira de Oncologia Cirúrgica (SBCO) sobre o manejo de malignidades da superfície peritoneal durante a pandemia de COVID-19

Bruno José de Queiroz Sarmento 
1   Brazilian Society of Surgical Oncology, Scientific Committee on Peritoneal Surface Malignancies - Rio de Janeiro - RJ - Brazil
2   Base Hospital of Federal District, Department of Sugical Oncology - Brasília - DF - Brazil
,
Daniel Paulino Santana
1   Brazilian Society of Surgical Oncology, Scientific Committee on Peritoneal Surface Malignancies - Rio de Janeiro - RJ - Brazil
3   Rede Mater Dei de Saúde, Surgical Oncology - Belo Horizonte - MG - Brazil
,
Andrea Petruzziello
1   Brazilian Society of Surgical Oncology, Scientific Committee on Peritoneal Surface Malignancies - Rio de Janeiro - RJ - Brazil
4   Marcelino Champagnat Hospital, Surgical Oncology - Curitiba - PR - Brazil
,
Rafael Seitenfus
5   Santa Rita Hospital, Santa Casa de Misericórdia, Surgical Oncology - Porto Alegre - RS - Brazil
,
Cézar Augusto Vendas Galhardo
1   Brazilian Society of Surgical Oncology, Scientific Committee on Peritoneal Surface Malignancies - Rio de Janeiro - RJ - Brazil
6   Proncor Hospital, Advanced Center of Peritoneum - Campo Grande - MS - Brazil
,
Paulo Henrique de Sousa Fernandes
1   Brazilian Society of Surgical Oncology, Scientific Committee on Peritoneal Surface Malignancies - Rio de Janeiro - RJ - Brazil
7   Federal University of Uberlândia, Department of Sugical Oncology - Uberlândia - MG - Brazil
,
Reitan Ribeiro
1   Brazilian Society of Surgical Oncology, Scientific Committee on Peritoneal Surface Malignancies - Rio de Janeiro - RJ - Brazil
8   Erasto Gaertner Hospital, Department of Sugical Oncology - Curitiba - PR - Brazil
,
Heber Salvador de Castro Ribeiro
1   Brazilian Society of Surgical Oncology, Scientific Committee on Peritoneal Surface Malignancies - Rio de Janeiro - RJ - Brazil
9   AC Camargo Cancer Center, Abdominal Surgery - São Paulo - SP - Brazil
,
Alexandre Ferreira Oliveira
1   Brazilian Society of Surgical Oncology, Scientific Committee on Peritoneal Surface Malignancies - Rio de Janeiro - RJ - Brazil
10   Federal University of Juiz de Fora, Department of Oncology - Juiz de Fora - MG - Brazil
› Author Affiliations Financial support: none to declare.
› Further Information
   Permissions and Reprints All articles of this category

ABSTRACT

The present proposal aims to support and help clinicians how to manage peritoneal surface malignancies during COVID-19 pandemic. It is based on the opinions of surgical oncologists of Brazilian Society of Surgical Oncology (BSSO) and not necessarily evidencebased instructions.

RESUMO

A presente proposta tem como objetivo apoiar e ajudar os médicos a gerenciar doenças malignas da superfície peritoneal durante a pandemia de COVID-19. É baseada nas opiniões de cirurgiões oncológicos da Sociedade Brasileira de Cirurgia Oncológica (SBCO) e não necessariamente em instruções baseadas em evidências.

Keywords:

Pandemics - Surgical oncology - Peritoneal neoplasms

Palavras-Chave:

Pandemias - Cirurgia Oncológica - Neoplasiais peritoneais


Publication History

Received: 21 April 2020

Accepted: 30 April 2020

Article published online:
10 June 2020

© 2022. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Bibliographical Record
Bruno José de Queiroz Sarmento, Daniel Paulino Santana, Andrea Petruzziello, Rafael Seitenfus, Cézar Augusto Vendas Galhardo, Paulo Henrique de Sousa Fernandes, Reitan Ribeiro, Heber Salvador de Castro Ribeiro, Alexandre Ferreira Oliveira. Brazilian Society of Surgical Oncology (BSSO) considerations on peritoneal surface malignancies management during COVID-19 pandemic. Brazilian Journal of Oncology 2020; 16: e-20200008.
DOI: 10.5935/2526-8732.20200008
 

  • REFERENCES

  • Chua TC, Martin S, Saxena A, Liauw W, Yan TD, Zhao J. et al Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. Ann Surg 2010; Feb; 251 (02) 323-329 https://doi.org/10.1097/SLA.0b013e3181c9b53c
    Search in Google Scholar
  • Aminian A, Safari S, Razeghian-Jahromi A, Ghorbani M, Delaney CP. COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period. Ann Surg 2020; Mar; 26; Epub ahead of print
    Search in Google Scholar
  • Esquivel J, Garcia SS, Hicken W, Seibel J, Shekitka K, Trout R. Evaluation of a new staging classification and a Peritoneal Surface Disease Severity Score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination. J Surg Oncol 2014; Nov; 110 (06) 656-660 https://doi.org/10.1002/jso.23679
    Search in Google Scholar
  • Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN. et al Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012; Jul; 30 (20) 2449-2456 https://doi.org/10.1200/JCO.2011.39.7166
    Search in Google Scholar
  • Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O. et al Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 2009; Dec; 27 (36) 6237-6242 https://doi.org/10.1200/JCO.2009.23.9640
    Search in Google Scholar
  • Baratti D, Kusamura S, Cabras AD, Laterza B, Balestra MR, Deraco M. Lymph node metastases in diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 2010; Jan; 17 (01) 45-53 https://doi.org/10.1245/s10434-009-0756-2
    Search in Google Scholar
  • van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM. et al Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 2018; Jan; 378 (03) 230-240 https://doi.org/10.1056/NEJMoa1708618
    Search in Google Scholar
  • Quenet F, Elias D, Roca L, Goere D, Li Ghout, Pocard M. et al A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC):PRODIGE7. J Clin Oncol 2018; 36 (18 Suppl 1): LBA350 https://doi.org/10.1200/JCO.2018.36.18_suppl.LBA3503
    Search in Google Scholar
  • Nowacki M, Alyami M, Villeneuve L, Mercier F, Willaert W, Ceelen W. et al Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. Eur J Surg Oncol 2018; Jul; 44 (07) 991-996 https://doi.org/10.1016/j.ejso.2018.02.014
    Search in Google Scholar
  • Seitenfus R, Kalil AN, Barros ED, Fedrizzi G. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) through a single port: alternative delivery for the control of peritoneal metastases. Rev Col Bras Cir 2018; 45 (04) e1909 https://doi.org/10.1590/0100-6991e-20181909
    Search in Google Scholar
  • Delhorme JB, Klipfel A, D'Antonio F, Greget MC, Diemunsch P, Rohr S. et al Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow. J Visc Surg 2019; Dec; 156 (06) 485-488 https://doi.org/10.1016/j.jviscsurg.2019.06.010
    Search in Google Scholar
  • Graversen M, Lundell L, Fristrup C, Pfeiffer P, Mortensen MB. Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure. Pleura Peritoneum 2018; 3 (04) e20180128 https://doi.org/10.1515/pp-2018-0128
    Search in Google Scholar